FMP

FMP

Enter

LRMR - Larimar Therapeutics...

Terminal Value of Larimar Therapeutics, Inc.(LRMR), Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments

photo-url-https://financialmodelingprep.com/image-stock/LRMR.png

Larimar Therapeutics, Inc.

LRMR

NASDAQ

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

9.39 USD

-0.3 (-3.19%)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep